EssilorLuxottica has reaffirmed its goal to complete the acquisition of optical retail giant GrandVision within the next 18 months following the announcement of a new investigation by the European competition watchdog. Read more
Chinese ophthalmologist and coronavirus whistle-blower dies
An ophthalmologist who Chinese authorities attempted to silence during the initial stages of the coronavirus outbreak has died after contracting the disease himself from a glaucoma patient. Read more
Treatment for CSCR found to have “no benefit”
New research from the University of Bristol and University Hospital Southampton has concluded that eplerenone offers no benefit for patients suffering from central serous chorioretinopathy (CSCR), and subsequently should no longer be prescribed for the condition. Read more
Poor vision as detrimental to learning as poverty
New research from the World Bank and international charity organisation EYElliance has found that an unaddressed vision problem can be just as detrimental to a child’s learning as socio-economic disadvantage. Read more
Novartis targets Europe for next-generation AMD treatment
Novartis’ new therapy for neovascular age-related macular degeneration (nAMD) has advanced part-way through the European regulatory process after winning the approval of independent advisors. Read more
Zeiss posts tenth consecutive record-breaking year
The Zeiss Group’s Medical Technology segment, as well as its the Vision Care unit, has been announced as a major contributor to the group’s record-breaking financial success over the last year. Read more
BHVI strengthens East Asia presence in new deal
Epidemiological studies and clinical trials involving optical devices for myopia will be the focus of a new three-year agreement between the Brien Holden Vision Institute (BHVI) and a leading Chinese eye hospital network. Read more
Alcon announces plan for ‘multi-year transformation program’
Alongside its third quarter results for 2019, Alcon has announced a multi-year transformation program to invest in strategic growth initiatives. Read more
Australian students awarded global scholarships
Four Australian students have been awarded Practice Excellence Scholarships from the American Academy of Optometry Foundation (AAOF) for their outstanding academic performance and commitment to independent optometry. Read more
CooperVision’s MiSight receives FDA approval, to launch in 2020
CooperVision has received clearance from the US Food and Drug Administration (FDA) for its MiSight 1 Day Contact Lens for Childhood Myopia. Read more